Although research around the world is being impacted by COVID-19 pandemic, Science 37 has you covered.

Our COVID-19 business continuity solution can help virtualize study visits for those engaged in research at traditional sites and connect patients with investigators in real time. In addition to enabling on-demand telemedicine, IMP tracking, eConsent, and ePROs with this platform, researchers have the ability to collect a variety of high-level trial data.

Available globally with rapid deployment, this solution helps research continue in an affordable, highly scalable, 21 CFR Part 11–compliant platform with an audit trail.